2017 Medicare Part D Formulary Change
|
|
- Margery Shields
- 6 years ago
- Views:
Transcription
1 2017 Medicare Part D Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy restrictions on a drug (or move a drug to a higher cost-sharing tier), we will let you know of the change at least 60 days before the date that the change becomes effective. However, if the Food and Drug Administration deems a drug on our formulary to be unsafe or the drug s manufacturer removes the drug from the market, we will immediately remove the drug from our formulary and let you know. The product changes noted below will be implemented on the Medicare Part D Plan: New Added Products: Effective 11/1/2017 adapalene 0.1 %-benzoyl peroxide 2.5 % topical gel with pump BENLYSTA 200 MG/ML SUBCUTANEOUS AUTO- INJECTOR BENLYSTA 200 MG/ML SUBCUTANEOUS SYRINGE PA New Drug Tier 4 New Drug Tier 4 diazepam 2.5 mg rectal kit diazepam 5 mg-7.5 mg-10 mg rectal kit estradiol 10 mcg vaginal tablet IDHIFA 100 MG TABLET New Drug Tier 4 PA QL LA IDHIFA 50 MG TABLET New Drug Tier 4 PA QL LA ISENTRESS HD 600 MG TABLET New Drug Tier 4 LYNPARZA 100 MG TABLET New Drug Tier 4 PA LYNPARZA 150 MG TABLET New Drug Tier 4 PA NERLYNX 40 MG TABLET New Drug Tier 4 LA prasugrel 10 mg tablet prasugrel 5 mg tablet 1 "*Consult your Medical provider for changes or recommendations to your medical care and prescription therapy **Please consult the plan benefit design for copay/coinsurance amounts ***Indicates a restriction of Step Therapy, Prior Authorization or Quantity Limits may exist [LA] = Limited Access, [PA] = Prior Authorization, [QL] = Quantity Limit, [ST] = Step Therapy PRF-C4T"
2 RADICAVA 30 MG/100 ML INTRAVENOUS PIGGYBACK New Drug Tier 4 vigabatrin 500 mg oral powder packet New Drug Tier 4 LA VYXEOS 44 MG-100 MG INTRAVENOUS SOLUTION New Drug Tier 4 PA ZYTIGA 500 MG TABLET New Drug Tier 4 PA QL Future Removed Products: There were no future removed products this month. Cost Sharing Tier Changes: There were no cost sharing tier changes this month. New Added Products: Effective 10/1/2017 AMNESTEEM 10 MG CAPSULE New Drug Tier 3 AMNESTEEM 20 MG CAPSULE New Drug Tier 3 AMNESTEEM 40 MG CAPSULE desogestrel 0.15 mg-ethinyl estradiol 0.03 mg tablet eletriptan hbr 20 mg tablet eletriptan hbr 40 mg tablet ISIBLOOM 0.15 MG-0.03 MG TABLET JADENU SPRINKLE 180 MG ORAL GRANULES IN PACKET JADENU SPRINKLE 360 MG ORAL GRANULES IN PACKET JADENU SPRINKLE 90 MG ORAL GRANULES IN PACKET Tier 4 Tier 4 Tier 4 meropenem 1 gram intravenous solution mesalamine 1.2 gram tablet,delayed release moxifloxacin 0.5 % eye drops ORFADIN 20 MG CAPSULE New Drug Tier 4 LA sevelamer carbonate 800 mg tablet 2 "*Consult your Medical provider for changes or recommendations to your medical care and prescription therapy **Please consult the plan benefit design for copay/coinsurance amounts ***Indicates a restriction of Step Therapy, Prior Authorization or Quantity Limits may exist [LA] = Limited Access, [PA] = Prior Authorization, [QL] = Quantity Limit, [ST] = Step Therapy PRF-C4T"
3 testosterone 30 mg/actuation (1.5 ml) transderm solution metered pump PA XATMEP 2.5 MG/ML ORAL SOLUTION New Drug Tier 4 PA Future Removed Products: There were no future removed products this month. Cost Sharing Tier Changes: There were no cost sharing tier changes this month. New Added Products: Effective 9/1/2017 ARISTADA 1,064 MG/3.9 ML SUSPENSION, EXTEND.REL. IM SYRINGE New Drug Tier 4 atomoxetine 10 mg capsule atomoxetine 100 mg capsule atomoxetine 18 mg capsule atomoxetine 25 mg capsule atomoxetine 40 mg capsule atomoxetine 60 mg capsule atomoxetine 80 mg capsule DIASTAT 2.5 MG RECTAL KIT DIASTAT ACUDIAL 12.5 MG-15 MG-17.5 MG-20 MG RECTAL KIT DIASTAT ACUDIAL 5 MG-7.5 MG-10 MG RECTAL KIT Tier 3 Tier 3 Tier 3 lidocaine (pf) 10 mg/ml (1 %) injection solution NOLIX 0.05 % LOTION olopatadine 0.2 % eye drops ORENCIA 50 MG/0.4 ML SUBCUTANEOUS SYRINGE ORENCIA 87.5 MG/0.7 ML SUBCUTANEOUS SYRINGE New Drug Tier 4 PA New Drug Tier 4 PA 3 "*Consult your Medical provider for changes or recommendations to your medical care and prescription therapy **Please consult the plan benefit design for copay/coinsurance amounts ***Indicates a restriction of Step Therapy, Prior Authorization or Quantity Limits may exist [LA] = Limited Access, [PA] = Prior Authorization, [QL] = Quantity Limit, [ST] = Step Therapy PRF-C4T"
4 sevelamer carbonate 0.8 gram oral powder packet sevelamer carbonate 2.4 gram oral powder packet VARIZIG 125 UNIT/1.2 ML INTRAMUSCULAR SOLUTION Future Removed Products: Effective 9/1/2017 New Drug Tier 4 New Drug Tier 4 New Drug Tier 2 Drug Description of Change Reason for Change Alternative Drug Alternative Drug Tier LORTAB 10 MG-325 MG TABLET name, will no longer be covered by the Medicare Part D portion of your benefit. name, is no longer being marketed. Please contact your doctor. Will vary based on the drug prescribed. Cost Sharing Tier Changes: There were no cost sharing tier changes this month. New Added Products: Effective 8/1/2017 ALUNBRIG 30 MG TABLET New Drug Tier 4 PA QL LA clofarabine 20 mg/20 ml intravenous solution New Drug Tier 4 ezetimibe 10 mg-simvastatin 10 mg tablet QL ezetimibe 10 mg-simvastatin 20 mg tablet QL ezetimibe 10 mg-simvastatin 40 mg tablet QL ezetimibe 10 mg-simvastatin 80 mg tablet QL IMFINZI 50 MG/ML INTRAVENOUS SOLUTION New Drug Tier 4 LA IMFINZI 50 MG/ML INTRAVENOUS SOLUTION (10 ML) KISQALI FEMARA CO-PACK 200 MG/DAY(200 MG X 1)-2.5 MG TABLET New Drug Tier 4 LA New Drug Tier 4 PA 4 "*Consult your Medical provider for changes or recommendations to your medical care and prescription therapy **Please consult the plan benefit design for copay/coinsurance amounts ***Indicates a restriction of Step Therapy, Prior Authorization or Quantity Limits may exist [LA] = Limited Access, [PA] = Prior Authorization, [QL] = Quantity Limit, [ST] = Step Therapy PRF-C4T"
5 KISQALI FEMARA CO-PACK 400 MG/DAY(200 MG X 2)-2.5 MG TABLET KISQALI FEMARA CO-PACK 600 MG/DAY(200 MG X 3)-2.5 MG TABLET New Drug Tier 4 PA New Drug Tier 4 PA RYDAPT 25 MG CAPSULE New Drug Tier 4 PA TYMLOS 80 MCG/DOSE (3,120 MCG/1.56 ML) SUBCUTANEOUS PEN INJECTOR New Drug Tier 4 PA QL XATMEP 2.5 MG/ML ORAL SOLUTION New Drug Tier 4 PA ZEJULA 100 MG CAPSULE New Drug Tier 4 PA QL LA 5 "*Consult your Medical provider for changes or recommendations to your medical care and prescription therapy **Please consult the plan benefit design for copay/coinsurance amounts ***Indicates a restriction of Step Therapy, Prior Authorization or Quantity Limits may exist [LA] = Limited Access, [PA] = Prior Authorization, [QL] = Quantity Limit, [ST] = Step Therapy PRF-C4T"
6 Future Removed Products: Effective 8/1/2017 Drug Description of Change Reason for Change Alternative Drug Alternative Drug Tier DEXEDRINE 5 MG TABLET name, will no longer be covered by the Medicare Part D portion of your benefit. name, is no longer being marketed. Please contact your doctor. Will vary based on the drug prescribed. DEXEDRINE 10 MG TABLET name, will no longer be covered by the Medicare Part D portion of your benefit. name, is no longer being marketed. Please contact your doctor. Will vary based on the drug prescribed. Cost Sharing Tier Changes: There were no cost sharing tier changes this month. New Added Products: Effective 7/1/2017 BAVENCIO 20 MG/ML INTRAVENOUS SOLUTION New Drug Tier 4 LA busulfan 60 mg/10 ml intravenous solution New Drug Tier 4 DUPIXENT 300 MG/2 ML SUBCUTANEOUS SYRINGE New Drug Tier 4 PA ESBRIET 267 MG TABLET New Drug Tier 4 PA QL ESBRIET 801 MG TABLET New Drug Tier 4 PA QL FAYOSIM 0.15 MG-20 MCG/0.15 MG-25 MCG TABLETS,3 MONTH DOSE PACK INTRON A 10 MILLION UNIT/ML INJECTION SOLUTION KINRIX (PF) 25 LF-58 MCG-10 LF/0.5 ML INTRAMUSCULAR SUSPENSION levoleucovorin 50 mg intravenous powder for solution norethindrone 1 mg-e. estradiol 20 mcg (24)- iron 75 mg (4) chew tablet RIVELSA 0.15 MG-20 MCG/0.15 MG-25 MCG TABLETS,3 MONTH DOSE PACK New Drug Tier 2 New Drug Tier 2 New Drug Tier 4 6
7 ROWEEPRA 1,000 MG TABLET ROWEEPRA 750 MG TABLET tazarotene 0.1 % topical cream PA VIBATIV 750 MG INTRAVENOUS SOLUTION New Drug Tier 2 zileuton er 600 mg tablet,extended release 12hr mphase New Drug Tier 4 7
8 Future Removed Products: There were no future removed products this month. Cost Sharing Tier Changes: There were no cost sharing tier changes this month. New Added Products: Effective 6/1/2017 desvenlafaxine succinate er 100 mg tablet,extended release 24 hr desvenlafaxine succinate er 25 mg tablet,extended release 24 hr desvenlafaxine succinate er 50 mg tablet,extended release 24 hr QL QL QL KISQALI 200 MG/DAY (200 MG X 1) TABLET New Drug Tier 4 PA KISQALI 400 MG/DAY (200 MG X 2) TABLET New Drug Tier 4 PA KISQALI 600 MG/DAY (200 MG X 3) TABLET New Drug Tier 4 PA MIBELAS 24 FE 1 MG-20 MCG (24)/75 MG (4) CHEWABLE TABLET naftifine 1 % topical cream Tier 1 XERMELO 250 MG TABLET New Drug Tier 4 LA Future Removed Products: There were no future removed products this month. Cost Sharing Tier Changes: There were no cost sharing tier changes this month New Added Products: Effective 5/1/2017 calcium acetate 667 mg tablet CLINDACIN P 1 % TOPICAL SWAB epinephrine 0.3 mg/0.3 ml injection, autoinjector (manufactured by Mylan) Tier 1 New Drug Tier 2 8
9 fenofibrate 120 mg tablet fenofibrate 40 mg tablet Tier 1 Tier 1 flurandrenolide 0.05 % topical ointment KLOR-CON M10 MEQ TABLET,EXTENDED RELEASE KLOR-CON M20 MEQ TABLET,EXTENDED RELEASE LINZESS 72 MCG CAPSULE New Drug Tier 2 MENOMUNE - A/C/Y/W-135 (PF) 50 MCG SUBCUTANEOUS SOLUTION methylphenidate er 20 mg multiphase capsule 30-70,extended release methylphenidate er 40 mg multiphase capsule 30-70,extended release methylphenidate la 60 mg capsule,extended release biphasic potassium chloride er 10 meq tablet,extended release(part/cryst) potassium chloride er 20 meq tablet,extended release(part/cryst) prednisolone sodium phosphate 10 mg/5 ml oral solution prednisolone sodium phosphate 20 mg/5 ml (4 mg/ml) oral solution New Drug Tier 2 SELZENTRY 25 MG TABLET New Drug Tier 2 SELZENTRY 75 MG TABLET New Drug Tier 2 Future Removed Products: There were no future removed products this month. Cost Sharing Tier Changes: Effective 5/1/2017 9
10 Drug New Tier Old Tier Restrictions*** doxercalciferol 0.5 mcg capsule 1 3 LEVETIRACETAM 1,000 MG/100 ML IN SODIUM CHLORIDE(ISO-OSM) IV PIGGYBACK LEVETIRACETAM 1,500 MG/100 ML IN SODIUM CHLORIDE(ISO-OSM) IV PIGGYBACK LEVETIRACETAM 500 MG/100 ML IN SODIUM CHLORIDE (ISO-OSM) IV PIGGYBACK New Added Products: Effective 4/1/2017 ADCIRCA 20 MG TABLET Tier 4 amiodarone 100 mg tablet ANDRODERM 2 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH ANDRODERM 4 MG/24 HR TRANSDERMAL 24 HOUR PATCH AZASITE 1 % EYE DROPS dexmethylphenidate er 25 mg capsule,extended release biphasic50-50 dexmethylphenidate er 35 mg capsule,extended release biphasic50-50 GAMASTAN S/D 15 %-18 % RANGE INTRAMUSCULAR SOLUTION (10 ML) GAMASTAN S/D 15 %-18 % RANGE INTRAMUSCULAR SOLUTION (2 ML) IMOGAM RABIES-HT (PF) 150 UNIT/ML INTRAMUSCULAR SOLUTION lopinavir-ritonavir 400 mg-100 mg/5 ml oral solution Tier 2 Tier 2 Tier 2 Tier 2 Tier 2 Tier 2 PA QL PA PA 10
11 norgestimate 0.25 mg-ethinyl estradiol 35 mcg tablet ranitidine 50 mg/2 ml (25 mg/ml) injection solution RIBASPHERE RIBAPAK 200 MG (7)-400 MG (7) TABLETS IN A DOSE PACK STIOLTO RESPIMAT 2.5 MCG-2.5 MCG/ACTUATION SOLUTION FOR INHALATION Tier 2 Future Removed Products: There were no future removed products this month. Cost Sharing Tier Changes: Effective 4/1/2017 Drug New Tier Old Tier Restrictions*** doxycycline hyclate 200 mg tablet,delayed release 1 4 EDARBI 40 MG TABLET 2 3 EDARBI 80 MG TABLET 2 3 EDARBYCLOR 40 MG-12.5 MG TABLET 2 3 EDARBYCLOR 40 MG-25 MG TABLET 2 3 QL New Added Products: Effective 3/1/2017 abacavir 600 mg-lamivudine 300 mg tablet New Drug Tier 4 ADRIAMYCIN 20 MG/10 ML INTRAVENOUS SOLUTION ALA-CORT 2.5 % TOPICAL CREAM allopurinol 500 mg intravenous solution ALYACEN 1/35 (28) 1 MG-35 MCG TABLET AMABELZ 0.5 MG-0.1 MG TABLET AMABELZ 1 MG-0.5 MG TABLET 11
12 AMETHIA LO 0.10 MG-20 MCG (84)/10 MCG(7) TABLETS,3 MONTH DOSE PACK amlodipine 10 mg-olmesartan 20 mg tablet amlodipine 10 mg-olmesartan 40 mg tablet amlodipine 5 mg-olmesartan 20 mg tablet amlodipine 5 mg-olmesartan 40 mg tablet aprepitant 125 mg (1)-80 mg (2) capsules in a dose pack PA aprepitant 125 mg capsule PA aprepitant 40 mg capsule PA aprepitant 80 mg capsule PA AZACTAM 1 GRAM/50 ML IN DEXTROSE (ISO- OSMOTIC) INTRAVENOUS PIGGYBACK Tier 2 azithromycin 500 mg tablet (3 pack) BEVESPI AEROSPHERE 9 MCG-4.8 MCG HFA AEROSOL INHALER bupropion hcl 150 mg tablet,sustained release (as a smoking deterrent) New Drug Tier 2 QL BYVALSON 5 MG-80 MG TABLET New Drug Tier 2 CAMRESE LO 0.10 MG-20 MCG (84)/10 MCG(7) TABLETS,3 MONTH DOSE PACK CAZIANT (28) 0.1 MG/0.125 MG/0.15 MG-25 MCG TABLET CHOLESTYRAMINE LIGHT 4 GRAM ORAL POWDER CLEOCIN 100 MG VAGINAL SUPPOSITORY clindamycin 1.2 % (1 % base)-benzoyl peroxide 5 % topical gel Tier 2 clindamycin-tretinoin 1.2 % % topical gel PA daptomycin 500 mg intravenous solution New Drug Tier 4 drospiren-e.estrad-l.mefol 3 mg-0.02 mg mg(24)/0.451 mg(4)tablet 12
13 EMEND 125 MG (25 MG/ML FINAL CONC.) ORAL SUSPENSION New Drug Tier 2 PA EPCLUSA 400 MG-100 MG TABLET New Drug Tier 4 PA QL epinephrine 0.15 mg/0.3 ml injection,autoinjector New Drug Tier 2 epirubicin 200 mg/100 ml intravenous solution ergotamine 1 mg-caffeine 100 mg tablet erythromycin ethylsuccinate 200 mg/5 ml oral powder for suspension ethacrynic acid 25 mg tablet ethynodiol diac-eth estradiol 1 mg-50 mcg tablet ezetimibe 10 mg tablet FEMYNOR 0.25 MG-35 MCG TABLET FLOXIN 0.3 % EAR DROPS FLUOCINONIDE-E 0.05% TOPICAL CREAM flurandrenolide 0.05 % lotion GENGRAF 50 MG CAPSULE PA HUMIRA PEN PSORIASIS-UVEITIS STARTER 40 MG/0.8 ML SUBCUTANEOUS KIT New Drug Tier 4 PA QL INFLECTRA 100 MG INTRAVENOUS SOLUTION New Drug Tier 4 PA INVOKAMET XR 150 MG-1,000 MG TABLET, EXTENDED RELEASE INVOKAMET XR 150 MG-500 MG TABLET, EXTENDED RELEASE INVOKAMET XR 50 MG-1,000 MG TABLET, EXTENDED RELEASE INVOKAMET XR 50 MG-500 MG TABLET, EXTENDED RELEASE KINRIX (PF) 25 LF-58 MCG-10 LF/0.5 ML INTRAMUSCULAR SYRINGE New Drug Tier 2 QL New Drug Tier 2 QL New Drug Tier 2 QL New Drug Tier 2 QL New Drug Tier 2 KYPROLIS 30 MG INTRAVENOUS SOLUTION New Drug Tier 4 KYPROLIS 60 MG INTRAVENOUS SOLUTION New Drug Tier 4 13
14 LARISSIA 0.1 MG-20 MCG TABLET LARTRUVO 10 MG/ML INTRAVENOUS SOLUTION levalbuterol 1.25 mg/0.5 ml solution for nebulization (2.5 mg/ml) New Drug Tier 4 LA New Drug Tier 3 PA LORCET HD 10 MG-325 MG TABLET QL LOW-OGESTREL (28) 0.3 MG-30 MCG TABLET MAXIPIME 1 GRAM SOLUTION FOR INJECTION MAXIPIME 2 GRAM SOLUTION FOR INJECTION metformin er 1,000 mg 24 hr tablet,extended release metformin er 500 mg 24 hr tablet,extended release metformin er 500 mg tablet,extended release 24hr metformin er tablet,extended release 24hr (osmotic) methotrexate sodium 25 mg/ml injection solution methylphenidate er 20 mg multiphase capsule 30-70,extended release methylphenidate er 40 mg multiphase capsule 30-70,extended release Tier 3 Tier 3 New Drug Tier 3 QL New Drug Tier 3 QL New Drug Tier 3 QL New Drug Tier 3 QL PA MORGIDOX 50 MG CAPSULE mycophenolate 500 mg intravenous solution PA NAMZARIC 21 MG-10 MG CAPSULE SPRINKLE,EXTENDED RELEASE NAMZARIC 7 MG-10 MG CAPSULE SPRINKLE,EXTENDED RELEASE NAMZARIC 7/14/21/28 MG-10 MG CAPSULE,SPRINKLE,ER 24HR,DOSE PACK New Drug Tier 2 PA New Drug Tier 2 PA New Drug Tier 2 PA 14
15 nifedipine er 30 mg tablet,extended release 24 hr nifedipine er 60 mg tablet,extended release 24 hr nifedipine er 90 mg tablet,extended release 24 hr nilutamide 150 mg tablet New Drug Tier 4 nitroglycerin 0.3 mg sublingual tablet nitroglycerin 0.4 mg sublingual tablet nitroglycerin 0.6 mg sublingual tablet norethin-ethinyl estradiol-iron 0.4 mg-35 mcg(21)/75 mg(7) chew tablet norethindrone acetate 1 mg-ethinyl estradiol 20 mcg tablet norgestimate-ethinyl estradiol 0.18 mg/0.215mg/0.25mg-35 mcg(28)tablet NYATA 100,000 UNIT/GRAM TOPICAL POWDER OCALIVA 10 MG TABLET New Drug Tier 4 PA QL LA OCALIVA 5 MG TABLET New Drug Tier 4 PA QL LA ofloxacin 300 mg tablet olmesartan 20 mg tablet olmesartan 20 mg-amlodipine 5 mghydrochlorothiazide 12.5 mg tablet olmesartan 20 mg-hydrochlorothiazide 12.5 mg tablet olmesartan 40 mg tablet olmesartan 40 mg-amlodipine 10 mghydrochlorothiazide 12.5 mg tablet olmesartan 40 mg-amlodipine 10 mghydrochlorothiazide 25 mg tablet olmesartan 40 mg-amlodipine 5 mghydrochlorothiazide 12.5 mg tablet olmesartan 40 mg-amlodipine 5 mghydrochlorothiazide 25 mg tablet 15
16 olmesartan 40 mg-hydrochlorothiazide 12.5 mg tablet olmesartan 40 mg-hydrochlorothiazide 25 mg tablet olmesartan 5 mg tablet omeprazole 20 mg-sodium bicarbonate 1,680 mg oral packet omeprazole 40 mg-sodium bicarbonate 1,680 mg oral packet ORENCIA CLICKJECT 125 MG/ML SUBCUTANEOUS AUTO-INJECTOR QL New Drug Tier 4 PA ORKAMBI 100 MG-125 MG TABLET New Drug Tier 4 PA QL oseltamivir 30 mg capsule oseltamivir 45 mg capsule oseltamivir 75 mg capsule OTOVEL 0.3 % % (0.25 ML) EAR SOLUTION PEDIARIX (PF) 10 MCG-25 LF-25 MCG-10 LF/0.5 ML INTRAMUSCULAR SYRINGE pramipexole er 3.75 mg tablet,extended release 24 hr New Drug Tier 2 New Drug Tier 2 prednisone 10 mg tablets in a dose pack prednisone 10 mg tablets in a dose pack (48 pack) prednisone 5 mg tablets in a dose pack prednisone 5 mg tablets in a dose pack (48 pack) PRIMSOL 50 MG/5 ML ORAL SOLUTION New Drug Tier 3 quetiapine er 150 mg tablet,extended release 24 hr quetiapine er 200 mg tablet,extended release 24 hr quetiapine er 300 mg tablet,extended release 24 hr QL QL QL 16
17 quetiapine er 400 mg tablet,extended release 24 hr quetiapine er 50 mg tablet,extended release 24 hr QL QL rasagiline 0.5 mg tablet rasagiline 1 mg tablet REPATHA PUSHTRONEX 420 MG/3.5 ML SUBCUTANEOUS WEARABLE INJECTOR New Drug Tier 4 PA QL RUBRACA 200 MG TABLET New Drug Tier 4 PA QL LA RUBRACA 300 MG TABLET New Drug Tier 4 PA QL LA SPS (WITH SORBITOL) 15 GRAM-20 GRAM/60 ML ORAL SUSPENSION SULFAMYLON 50 GRAM TOPICAL PACKET sumatriptan 4 mg/0.5 ml subcutaneous pen injector triamcinolone acetonide 55 mcg nasal spray aerosol Tier 2 QL QL valganciclovir 50 mg/ml oral solution New Drug Tier 4 VASCEPA 0.5 GRAM CAPSULE New Drug Tier 2 VEMLIDY 25 MG TABLET New Drug Tier 4 VIEKIRA XR 8.33 MG-50 MG MG-200 MG TABLET, EXTENDED RELEASE New Drug Tier 4 PA QL YONDELIS 1 MG INTRAVENOUS SOLUTION New Drug Tier 4 YUVAFEM 10 MCG VAGINAL TABLET ZARAH 3 MG-0.03 MG TABLET ZERIT 1 MG/ML ORAL SOLUTION Future Removed Products: Effective 3/1/2017 Tier 3 Drug Description of Change Reason for Change Alternative Drug Alternative Drug Tier 17
18 Drug Description of Change Reason for Change Alternative Drug Alternative Drug Tier ALTABAX 1 % TOPICAL OINTMENT CERVARIX VACCINE (PF) 20 MCG-20 MCG/0.5 ML INTRAMUSCULAR SYRINGE PLASMA-LYTE-56 IN 5 % DEXTROSE INTRAVENOUS SOLUTION stavudine 1 mg/ml oral solution name, will no longer be covered by the Medicare Part D portion of your benefit. name, will no longer be covered by the Medicare Part D portion of your benefit. name, will no longer be covered by the Medicare Part D portion of your benefit. name, will no longer be covered by the Medicare Part D portion of your benefit. name, is no longer being marketed. name, is no longer being marketed. name, is no longer being marketed. name, is no longer being marketed. Please contact your physician. Please contact your physician. Please contact your physician. Please contact your physician. Will vary based on the drug prescribed. Will vary based on the drug prescribed. Will vary based on the drug prescribed. Will vary based on the drug prescribed. Cost Sharing Tier Changes: Effective 3/1/2017 Drug New Tier Old Tier Restrictions*** cefoxitin 2 gram intravenous solution 1 3 dapsone 100 mg tablet 1 2 dapsone 25 mg tablet 1 2 meropenem 500 mg intravenous solution 1 3 metformin er 500 mg tablet,extended release 24 hr morphine er 60 mg capsule,extended release 24 hr multiphase propafenone er 225 mg capsule,extended release 12 hr THEO MG CAPSULE,EXTENDED RELEASE THEO MG CAPSULE,EXTENDED RELEASE 1 3 QL 1 3 QL
19 THEO MG CAPSULE,EXTENDED RELEASE THEO MG CAPSULE,EXTENDED RELEASE Drug New Tier Old Tier Restrictions*** VARUBI 90 MG TABLET 2 3 PA 19
20 For more information about how these changes may affect your cost-sharing, such as copayments or coinsurance, or for more information about asking for an updated coverage determination or a formulary exception, please see the plan Evidence of Coverage. Alternative drugs are drugs in the same therapeutic category/class as the affected drug. Only your doctor can determine alternative drugs that are appropriate for you given the individualized nature of drug therapy. Please talk to your doctor about any changes or recommendations to your medical care and prescription drug therapy. Alternative drugs and additional information about formulary changes can be found on the plan formulary, *Consult your Medical provider for changes or recommendations to your medical care and prescription therapy **Please consult the plan benefit design for copay/coinsurance amounts ***Indicates a restriction of Step Therapy, Prior Authorization or Quantity Limits may exist [LA] = Limited Access, [PA] = Prior Authorization, [QL] = Quantity Limit, [ST] = Step Therapy ACS-O4T Note to existing members: This formulary has changed since last year. Please review this document to make sure that it still contains the drugs you take. Beneficiaries must use network pharmacies to access their premium and/or copayment/coinsurance may change on January 1, This document includes EmblemHealth Medicare PDP partial formulary as of November 1, For a complete, updated formulary, please visit our Web site at or call the Customer Service number below: For alternative formats or language, please call Customer Service toll free at: EmblemHealth Medicare PDP: , 24 hours a day, 7 days a week TTY/TDD users should call , 24 hours a day, 7 days a week v17 20
Partners Notice of Change March 2017
New Added Products: Effective 3/1/2017 Drug Reason Tier Restrictions abacavir 600 mg-lamivudine 300 QL ADRENACLICK 0.15 MG/0.15 ML INJECTION,AUTO- INJECTOR ADRENACLICK 0.3 MG/0.3 ML INJECTION, AUTO- INJECTOR
More information2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More information2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More information2017 Medicare Part D Formulary Change
2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationHealth Partners Medicare Special (2017) Updates
March 2017 Effective Date Brand Name EVZIO erythromycin ethylsuccinate naloxone hcl Generic Name erythromycin ethylsuccinate Type of Change Previous Value New Value ofloxacin ofloxacin NAMZARIC NAMZARIC
More informationYou ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.
3/1/2018 Medicare Part D Formulary Change In an effort to cover the most needed, cost-effective prescriptions, the AlohaCare Advantage Plus (HMO SNP) Formulary is updated monthly. The following are drugs
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More information2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationHealth Partners Medicare Prime and Value (2017) Updates
March/April 2017 Effective Date Brand Name Name Type of Change Previous Value New Value SPS sodium polystyrene sulfonate/sorbitol solution ORKAMBI ADRENACLICK ADRENACLICK levalbuterol tartrate hfa EXONDYS
More informationUpper Peninsula Health Plan Advantage (HMO) (H ) Updates
February, 2017 02/28/2017 abacavirlamivudine 02/28/2017 abacavirlamivudine 02/28/2017 rasagiline mesylate 02/28/2017 rasagiline mesylate abacavir sulfate/lamivudine ADD UM: QUANTITY 30 / 30 Days abacavir
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
More informationVIVA MEDICARE IMPORTANT T EXPANDED PERFORMANCE FORMULARY UPDATES
NORE/ETH/FER CHW 0.MG Added to the 07 //07 ALYACEN TAB / Added to the 07 //07 AMETHIA LO TAB Added to the 07 //07 ERGOT/CAFFEN TAB 00MG Added to the 07 //07 NORETH/ETHIN TAB /0 Added to the 07 //07 LORCET
More informationNOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
More information2017 Formulary Addendum Notice of Change (Prescription Drug Plans)
2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
207 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Plus Plan (HMO) H5087-002, H5087-07 This is a listing of the changes that have occurred in our formulary.
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Best Plan (HMO) H5087-005 This is a listing of the changes that have occurred in our formulary. Please
More information2016 Medicare Part D Formulary Change
2016 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
More informationSuperior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum
Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The
More information2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Freedom Plan (HMO SNP) H5087-001 This is a listing of the changes that have occurred in our formulary.
More information2016 Step Therapy (ST) Criteria
2016 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that
More information2017 Formulary Addendum Notice of Change
017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Choice (HMO), WellCare Essential (HMO-POS), WellCare Value (HMO) This is a listing of the changes that
More information2017 Formulary Addendum Notice of Change
2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred
More informationDuring non-business hours, your call will be answered by our automated phone system. A representative will return your call the next business day.
MEICARE AVANTAGE BlueCross BlueShield of Western New York 2018 Formulary Update BlueCross BlueShield of Western New York has updated its formulary (drug list) since its original publication in January
More informationHealth Partners Medicare Prime and Value (2017) Updates
March/April 2017 Effective Date Brand Name Name Type of Change Previous Value New Value SPS sodium polystyrene sulfonate/sorbitol solution ORKAMBI ADRENACLICK ADRENACLICK levalbuterol tartrate hfa EXONDYS
More information2017 Formulary Addendum Notice of Change
2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Access (HMO SNP), WellCare Liberty (HMO SNP), WellCare Reserve (HMO), WellCare Rx (HMO), WellCare Select
More informationAetna Better Health of Illinois Medicaid Formulary Updates
October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary
More information2018 Step Therapy (ST) Criteria
2018 Step Therapy (ST) Criteria Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a
More information2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
More informationMedicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary Changes Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
More informationMedicare Part D 2017 Formulary Changes Service To Senior
Medicare Part D 2017 Formulary s Service To Senior Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
More informationNeighborhood Medicaid Formulary Changes: June 2017
Neighborhood Medicaid Formulary Changes: June 2017 The following changes to the Neighborhood Medicaid Formulary were recently approved by the Pharmacy and Therapeutics (P&T) Committee. All changes were
More information2018 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
More informationMedicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 2017 Formulary Changes OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization,
More informationHealth Partners Medicare Special 2018 Formulary Changes
Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.
More information2015 Step Therapy (ST) Criteria
2015 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that
More informationMedicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
More informationMemorial Hermann Advantage HMO February 2019 Formulary Addendum
Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added
More information2018 Formulary Notice of Change Prescription Drug Plans
2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the
More informationALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018
Step Therapy Requirements Effective April 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone
More informationALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018
Step Therapy Requirements Effective June 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone
More informationReason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.
2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff
More informationMedicare Part D 2017 Formulary Changes OC Preferred
Medicare Part D 2017 Formulary s OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior authorization, quantity
More informationChanges to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies
Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs
More informationHealth Partners Medicare Prime 2019 Formulary Changes
Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes
More informationALLERGIC CONJUNCTIVITIS AGENTS
2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops
More informationJANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.
ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
More information2018 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: October 05, 2017 Effective Date: January 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
More informationAcyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria
Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time
More information2017 Step Therapy (ST) Criteria
2017 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that
More informationNotice of Mid-Year Changes to 2019 Paramount Enhanced Formulary
Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the
More information2018 Step Therapy (ST) Criteria
2018 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More information2017 Step Therapy Criteria
FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.
More information2019 Formulary Update
MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document
More informationFORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS
FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs
More informationQuarterly pharmacy formulary change notice
Quarterly pharmacy formulary change notice Provider update Summary: The formulary changes listed in the table below were reviewed and approved at our second quarter 2018, Pharmacy and Therapeutics Committee
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.
More informationALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017
ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone 15 mg tablet alogliptin 12.5 mg-pioglitazone
More informationTennCare Program TN MAC Price Change List As of: 03/30/2017
1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017
More informationACYCLOVIR OINT (CCHP2017)
ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN
More informationANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY
South Country Health Alliance 2017 Step Therapy Formulary ID: 17431 Last Updated: 10/20/2017 Effective Date: 11-01-2017 ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY BENICAR 20 MG BENICAR 40 MG BENICAR 5
More informationDecember 2016 Formulary Updates
December 2016 Formulary Updates ABACAVIR/LAMIVUDINE AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-20MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 10-40MG QL AMLODIPINE/OLMESARTAN MEDOXOMIL TAB 5-20MG QL AMLODIPINE/OLMESARTAN
More informationAlprazolam 0.25mg, 0.5mg, 1mg tablets
Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service
More informationWellCare s South Carolina Preferred Drug List Update
WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.
More informationate Formulary Upda ). We are open: October 1 February 8 a.m. 8 a.m. February drugs: You ask us to pay Formulary attached If you
MEDICARE ADVANTAGE HealthNow New York Formulary Upda ate Please note, the HealthNow New York Formulary has been updated since its original printing in September, 2015. This insert outlines all of the updates
More informationANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria
ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet
More informationANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019
Step Therapy Requirements Effective April 1, 2019 ANTIEMETICS STEP Sancuso 3.1 mg/24 hour transdermal patch Zuplenz 4 mg oral soluble film Zuplenz 8 mg oral soluble film COVERAGE OF CERTAIN BRAND NAME
More informationStep Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
More informationWellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum
WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you
More information5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details
5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS
More information5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release
Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda
More informationStep Therapy Requirements. Effective: 05/01/2018
Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG
More informationAPREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE
APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50
More information2018 CareOregon Advantage Part D Formulary Changes
2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD
More informationYour prescription benefit updates Formulary Updates - Effective January 1, 2019
Your prescription benefit updates Formulary Updates - Effective January 1, 2019 Medications are grouped by the conditions they treat. Each medication is placed in a tier that shows the amount you will
More informationQuarterly pharmacy formulary change notice
Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the
More informationMercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir
Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires
More informationTN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018
1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25
More informationNetwork Health Insurance Corporation Upcoming Negative Changes to the Medicare Part D Formulary
Requesting an Exception to the Formulary You can ask Network Health Insurance Corporation to make an exception to our coverage rules. Generally, we will only approve your request for an exception if alternative
More informationPeach State Health Plan routinely reviews the medications available on the Preferred Drug
Effective date: December 27, 2016 Peach State Health Plan Preferred Drug List (PDL) Updates Q4 2016 Peach State Health Plan routinely reviews the medications available on the Preferred Drug List (PDL).
More information2018 Step Therapy Criteria (List of Step Therapy Criteria)
Step Therapy Criteria Last Updated: March 20, 2018 Effective Date: April 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-MEDICAID
More informationUPDATE Ohana QUEST Integration Medicaid
UPDATE Ohana QUEST Integration Medicaid Preferred Drug List June 29, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes
More informationDrug Formulary Update, April 2017 Commercial and State Programs
Drug Formulary Update, April 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,
More informationKansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria
APREPITANT Kansas Health Advantage (HMO SNP) 2018 Formulary Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL
More informationPharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update FIRST QUARTER 2017 P&T Committee Decisions effective March 1, 2017 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
More informationPPHP 2017 Formulary 2017 Step Therapy Criteria
ARISTADA Aristada Prefilled Syringe 1064 MG/3.9ML Intramuscular Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882
More informationStep Therapy Requirements
Step Therapy Requirements Denver Health Medicare Choice (HMO SNP)/Medicare Select (HMO) Effective: 09/01/2017 Updated 08/2017 ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet
More informationEmblem Medicaid 3Q18 Formulary Updates
ALKERAN 2 MG TABLET Removed from Formulary 7/9/2018 AMITIZA 24 MCG CAPSULES Removed from Formulary 7/9/2018 AMITIZA 8 MCG CAPSULE Removed from Formulary 7/9/2018 avo cream topical emulsion Removed from
More informationDrug Name Tier Drug Name Tier
Drug Name Tier Drug Name Tier ABELCET 100 MG/20 ML VIAL 4 ACETYLCYSTEINE 10% VIAL 2 ACETYLCYSTEINE 20% VIAL 2 ACYCLOVIR 1,000 MG/20 ML VIAL 2 ACYCLOVIR 500 MG/10 ML VIAL 2 ADRUCIL 500 MG/10 ML VIAL 2 ALBUTEROL
More information5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release
5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.
More information